Dalpiciclib combined with pyrotinib and endocrine therapy in women with ER-positive, HER2-positive advanced breast cancer: A prospective, multicenter, single-arm, phase 2 trial
达匹西利联合吡咯替尼和内分泌治疗ER阳性、HER2阳性晚期乳腺癌女性患者:一项前瞻性、多中心、单臂II期试验
期刊:PLoS Medicine
影响因子:9.9
doi:10.1371/journal.pmed.1004669
Zhang, Jian; Meng, Yanchun; Wang, Biyun; Wu, Xinhong; Zheng, Hongmei; Hu, Jing; Liu, Wei; Chen, Wenyan; Wang, Leiping; Cao, Jun; Tao, Zhonghua; Li, Ting; Ni, Sujie; Yu, Zhengyan; Sun, Lichun; Wang, Yun; Peng, Qiang; Wang, Song; Hu, Xin; Wang, Jianfei; Wu, Yijia; Hu, Xichun